Second Half Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Second Half Financial Partners's BMY Position: Q2 2026 in Review
Second Half Financial Partners increased its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, buying an estimated $100K and bringing the position to 11,545 shares worth $665K. The position accounts for 0.27% of the portfolio, ranked #49.
Second Half Financial Partners first reported a position in BMY in Q1 2022 and has held it in 4 quarters since. The position peaked at $3.85M in Q2 2022. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Second Half Financial Partners held 11,545 shares of Bristol-Myers Squibb worth $665K as of Q2 2026.
- Second Half Financial Partners bought 1,744 Bristol-Myers Squibb shares in Q2 2026, an estimated $100K.
- Bristol-Myers Squibb made up 0.27% of Second Half Financial Partners's portfolio in Q2 2026, its #49 holding.
- Second Half Financial Partners first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 4 quarters since.
- Second Half Financial Partners's Bristol-Myers Squibb position peaked at $3.85M in Q2 2022.
- 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Second Half Financial Partners's 13F filing for Q2 2026, filed 17 Jul 2026.